The global Anticoagulants Market is projected to reach USD 44,600 million by 2025, driven by the increasing prevalence of pulmonary embolism (PE), deep vein thrombosis (DVT), and cardiovascular diseases. With a CAGR of 7.80%, the market is expected to grow to USD 81,336.39 million by 2033. Key factors fueling this growth include the rising geriatric population, advancements in anticoagulant drug formulations, and increasing adoption of direct oral anticoagulants (DOACs). Additionally, ongoing research in novel anticoagulant therapies and growing awareness about stroke prevention and blood clot management are expected to drive market expansion.